Clinical Trial Update: Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining Advair in outpatients with COPD during an acute exacerbation. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)

Snippet

Sponsor: Laval University | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED